Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency Pharmaceutical Investing
Aravive Biologics Initiates Phase 1b Portion of Phase 1b/2 Clinical Trial of AVB-S6-500 in Platinum-Resistant Recurrent Ovarian Cancer Pharmaceutical Investing
MyoKardia Reports Positive Data from Phase 1b Single-Ascending Dose Clinical Trial of MYK-491 Pharmaceutical Investing
Keryx Biopharmaceuticals Stockholders Approve Merger with Akebia Therapeutics Pharmaceutical Investing
Phivida appoints Covet Public Relations as U.S. Public Relations Agency of Record Cannabis Investing News
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL201 for Parkinson’s Disease Pharmaceutical Investing
New Data from the AEROSURF® Phase 2b Clinical Program shows AEROSURF® Appears to Reduce Incidence and Severity of Bronchopulmonary Dysplasia in Preterm Infants with RDS Biotech Investing
